Abbott Laboratories (Pakistan) Limited (PSX: ABOT)
Pakistan
· Delayed Price · Currency is PKR 789.41
-11.11 (-1.39%)
At close: Oct 11, 2024
ABOT Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 60,432 | 55,475 | 49,258 | 42,570 | 35,283 | 30,156 | Upgrade
|
| Revenue Growth (YoY) | 16.62% | 12.62% | 15.71% | 20.65% | 17.00% | 1.47% | Upgrade
|
| Cost of Revenue | 46,137 | 43,715 | 34,821 | 26,554 | 23,499 | 21,675 | Upgrade
|
| Gross Profit | 14,295 | 11,760 | 14,436 | 16,015 | 11,784 | 8,480 | Upgrade
|
| Selling, General & Admin | 9,622 | 8,989 | 7,835 | 7,232 | 5,516 | 5,746 | Upgrade
|
| Other Operating Expenses | 523.84 | 303.19 | 590.58 | 777.55 | 602.55 | 288.1 | Upgrade
|
| Operating Expenses | 10,146 | 9,292 | 8,425 | 8,009 | 6,119 | 6,034 | Upgrade
|
| Operating Income | 4,149 | 2,468 | 6,011 | 8,006 | 5,666 | 2,447 | Upgrade
|
| Interest Expense | -17.85 | -22.18 | -25.41 | -54.48 | -70.39 | -43.19 | Upgrade
|
| Interest & Investment Income | 547.66 | 739.17 | 881.8 | 571.13 | 344.36 | 260.49 | Upgrade
|
| Currency Exchange Gain (Loss) | 210.91 | -1,341 | -779.79 | -240.34 | -105.83 | -223.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 220.93 | 225.69 | 154.39 | 108.9 | 150.21 | 81.63 | Upgrade
|
| EBT Excluding Unusual Items | 5,110 | 2,069 | 6,242 | 8,392 | 5,984 | 2,522 | Upgrade
|
| Gain (Loss) on Sale of Assets | 23.74 | 20.26 | -94.33 | 18.92 | 4.16 | 4.73 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -16.08 | Upgrade
|
| Other Unusual Items | - | 500.05 | - | - | 255.46 | - | Upgrade
|
| Pretax Income | 5,134 | 2,590 | 6,148 | 8,410 | 6,244 | 2,511 | Upgrade
|
| Income Tax Expense | 1,933 | 2,328 | 3,143 | 2,443 | 1,708 | 1,211 | Upgrade
|
| Net Income | 3,201 | 261.78 | 3,004 | 5,967 | 4,535 | 1,300 | Upgrade
|
| Net Income to Common | 3,201 | 261.78 | 3,004 | 5,967 | 4,535 | 1,300 | Upgrade
|
| Net Income Growth | 653.59% | -91.29% | -49.65% | 31.57% | 248.90% | -51.75% | Upgrade
|
| Shares Outstanding (Basic) | 98 | 98 | 98 | 98 | 98 | 98 | Upgrade
|
| Shares Outstanding (Diluted) | 98 | 98 | 98 | 98 | 98 | 98 | Upgrade
|
| Shares Change (YoY) | 0.07% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 32.69 | 2.67 | 30.69 | 60.95 | 46.33 | 13.28 | Upgrade
|
| EPS (Diluted) | 32.69 | 2.67 | 30.69 | 60.95 | 46.33 | 13.28 | Upgrade
|
| EPS Growth | 653.09% | -91.29% | -49.65% | 31.57% | 248.90% | -51.75% | Upgrade
|
| Free Cash Flow | 1,469 | -3,137 | 212.23 | 5,768 | 6,768 | -2,028 | Upgrade
|
| Free Cash Flow Per Share | 15.00 | -32.04 | 2.17 | 58.92 | 69.13 | -20.71 | Upgrade
|
| Dividend Per Share | - | - | 15.000 | 40.000 | 40.000 | 7.500 | Upgrade
|
| Dividend Growth | - | - | -62.50% | 0% | 433.33% | -62.50% | Upgrade
|
| Gross Margin | 23.65% | 21.20% | 29.31% | 37.62% | 33.40% | 28.12% | Upgrade
|
| Operating Margin | 6.87% | 4.45% | 12.20% | 18.81% | 16.06% | 8.11% | Upgrade
|
| Profit Margin | 5.30% | 0.47% | 6.10% | 14.02% | 12.85% | 4.31% | Upgrade
|
| Free Cash Flow Margin | 2.43% | -5.65% | 0.43% | 13.55% | 19.18% | -6.72% | Upgrade
|
| EBITDA | 5,756 | 3,966 | 7,368 | 9,119 | 6,649 | 3,338 | Upgrade
|
| EBITDA Margin | 9.52% | 7.15% | 14.96% | 21.42% | 18.85% | 11.07% | Upgrade
|
| D&A For EBITDA | 1,607 | 1,498 | 1,357 | 1,113 | 983.72 | 891.82 | Upgrade
|
| EBIT | 4,149 | 2,468 | 6,011 | 8,006 | 5,666 | 2,447 | Upgrade
|
| EBIT Margin | 6.87% | 4.45% | 12.20% | 18.81% | 16.06% | 8.11% | Upgrade
|
| Effective Tax Rate | 37.65% | 89.89% | 51.13% | 29.05% | 27.36% | 48.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.